Advanced topical drug delivery system for the management of vaginal candidiasis. - Wikidata - wikimedia - TriplyDB

Advanced topical drug delivery system for the management of vaginal candidiasis.

Advanced topical drug delivery system for the management of vaginal candidiasis.

http://www.wikidata.org/entity/Q38222794

about

Biomaterials-based nanofiber scaffold: targeted and controlled carrier for cell and drug delivery.A curcumin-loaded liquid crystal precursor mucoadhesive system for the treatment of vaginal candidiasis Impact of Hydroxychloroquine-Loaded Polyurethane Intravaginal Rings on Lactobacilli.A review of emerging trends in the treatment of tuberculosis.In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane.Archaeosomes: an excellent carrier for drug and cell delivery.Potential of novel drug delivery systems in the management of topical candidiasis.Recent Developments in Antimicrobial Polymers: A Review.Skin permeation of econazole nitrate formulated in an enhanced hydrophilic multiple emulsion.Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia.Expansible thermal gelling foam aerosol for vaginal drug delivery.Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride.Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment.Formulation, optimization and evaluation of curcumin-β-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy.Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.Diacerein-Loaded novel gastroretentive nanofiber system using PLLA: Development and in vitro characterization.Novel Intravaginal Drug Delivery System Based on Molecularly PEGylated Lipid Matrices for Improved Antifungal Activity of Miconazole Nitrate.

P2860

Q34455565-0E96D37B-50C1-4D3D-A31B-E09EC812CF76 Q35918840-51C3FEF5-880E-4156-9114-CC6E7E3B2543 Q36290546-5E529425-5CC8-4496-97CC-F69FE2DF329F Q38264545-D4F554BF-9285-41A4-85AA-F89504812C95 Q38369997-A8A096BB-DAAC-4DA2-B021-90B811B05708 Q38380341-9401B30A-3F28-4000-8CD3-2736BFB5A4FC Q39315981-C7D94BC1-F7F4-42DA-B071-744C63A291D3 Q40107966-6D972EE6-13FF-4CB4-B57C-DDF8F3E4F6A9 Q40497325-3C0FB6C0-5A7C-4F77-81EC-E38065153415 Q41921886-A37E439E-E7E1-40DA-B425-E2D80ABFDD4C Q41997100-F6009E8D-367E-4BD8-8B4A-9755AF9A81CE Q45193810-86933237-5E94-456F-85FA-62B685FF3377 Q48146036-82BA3A68-8559-475B-8E33-36B2E03D06D2 Q52882091-8ACE56C0-B987-4CDD-805B-355EB0A1A5A2 Q53379436-774D707C-3298-4A9E-9DF0-917DDB3A0779 Q53560526-23EA7715-9920-42AE-B2E7-79223C537493 Q55412938-F027EF9E-AFF0-4AD6-8498-51FD761BBEEC

P2860

Advanced topical drug delivery system for the management of vaginal candidiasis.

http://www.wikidata.org/entity/Q38222794

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Advanced topical drug delivery system for the management of vaginal candidiasis.

@en

type

label

Advanced topical drug delivery system for the management of vaginal candidiasis.

@en

prefLabel

Advanced topical drug delivery system for the management of vaginal candidiasis.

@en

P1433

Q38222794-0A9CFE87-197F-4652-915D-4A2DDED4C93B

P1476

Q38222794-125AAF1C-102A-4385-8795-46366C048932

P2093

Q38222794-86E54417-43C8-404A-99AE-64D0120AD134

Q38222794-96B81DFA-7894-4716-B849-D3392C078214

Q38222794-A9F09968-A539-45EC-AAF6-8E332E624766

Q38222794-E9499ADC-3B7A-4CE6-88CA-743F3DD457D0

P2860

Q38222794-00B7CA3B-AE49-4D52-8E58-9AB899C4D53D

Q38222794-0A2A57C8-88E7-40E7-ACF0-504ECD7C2FA8

Q38222794-0A533D50-5662-4D10-ADD8-CA4FDCE5BC89

Q38222794-0F6AA5E2-F0C3-40CF-915C-8DF7C0CB9038

Q38222794-15403A23-CA17-457A-9B08-DBE2C19DC48F

Q38222794-15E37AE4-AD62-4C7B-AD4A-B3D0D68B39E3

Q38222794-16360A2D-A3B0-4050-AE8C-9EE1F07E1D26

Q38222794-16CB1EA8-6E40-4769-88F2-DD2F89FC02EC

Q38222794-1F9BA096-A257-4009-B496-C34E9185902D

Q38222794-20F41F4B-8434-4B4A-AD92-ECC904B1E073

P304

Q38222794-7B81E2E1-8D2B-4846-A486-243D50E57929

P31

Q38222794-BCD096A0-CB37-4DF4-BEDE-5EE7D036AEB9

P356

Q38222794-BDDC65C8-352C-4E22-B275-6B39BA935B33

P407

Q38222794-086AD59A-86C6-4A72-9C56-73A0841A5E42

P433

Q38222794-148B5338-425D-42B7-B96C-5405044AE014

P478

Q38222794-07F4ED70-F533-44F8-A6A3-FDF9027192BC

P577

Q38222794-E7A3A907-68D2-4B97-A4C1-FF4FBB822287

P698

Q38222794-51FF11A2-ADB0-4F97-904A-D93A8609E76D

P921

Q38222794-01C7C87D-2DE5-45DD-8900-B6F9FF99EBE6

P356

10717544.2014.928760

P1433

P1476

Advanced topical drug delivery system for the management of vaginal candidiasis.

@en

P2093

Amit Kumar Goyal

http://www.w3.org/2001/XMLSchema#string

Goutam Rath

http://www.w3.org/2001/XMLSchema#string

Himmat Singh Johal

http://www.w3.org/2001/XMLSchema#string

Tarun Garg

http://www.w3.org/2001/XMLSchema#string

P2860

Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics

An investigation into the pathogenesis of vulvo-vaginal candidosis

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.

Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781

Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.

Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.

Hydrogels in pharmaceutical formulations.

Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis

Why consider vaginal drug administration?

P304

550-563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10717544.2014.928760

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24959937

http://www.w3.org/2001/XMLSchema#string

P921